Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 19;9(9):e19292.
doi: 10.1016/j.heliyon.2023.e19292. eCollection 2023 Sep.

Chemical characterization, antioxidant and antidiabetic activities of a novel polyherbal formulation comprising of Hordeum vulgare, Elettaria cardamomum and Cicer arietinum extracts

Affiliations

Chemical characterization, antioxidant and antidiabetic activities of a novel polyherbal formulation comprising of Hordeum vulgare, Elettaria cardamomum and Cicer arietinum extracts

Rabia Iqbal et al. Heliyon. .

Abstract

Diabetes mellitus (DM) is the most prevalent endocrine disorder. Numerous individual herbs possess anti-diabetic activity. The seeds of Hordeum vulgare, Elettaria cardamomum and Cicer arietinum are traditionally used to manage DM. The ambition of this work was to formulate the poly-herbal granules (PHGs) comprising of these three functional foods and evaluate their in-vitro antioxidant and antidiabetic potential. The dried seed extracts of Hordeum vulgare, Elettaria cardamomum and Cicer arietinum were used in a ratio of 2.5:1:1 to formulate PHGs by wet granulation method. The ratio of extracts was selected on the basis of traditional phytotherapies popularly used by local Hakeems of Pakistan to achieve glycemic control in diabetic patients resistant to traditional allopathic regime of medicine. The flow properties of developed PHGs were evaluated. The UV-Visible spectroscopic, Fourier Transform Infrared (FTIR) and HPLC-DAD of all seed extracts and PHGs were performed. The in-vitro antioxidant DPPH, FRAP, total antioxidant capacity (TAC) and Nitric Oxide (NO) scavenging assays were carried out on PHGs. The in-vitro antidiabetic activity of PHGs was investigated by alpha-amylase and alpha-glucosidase enzyme inhibition activity. The developed PHGs exhibited excellent flow properties. The UV-Vis spectra of all seed extracts and PHGs demonstrated peak at 278 nm showing the presence of flavonoids and phenols. The FTIR spectra confirmed the existence of flavonoids, and phenols along with amines in seed extracts as well as PHGs. The HPLC-DAD test revealed the existence of gallic acid, ascorbic acid, Quercetin-3-(caffeoyldiglucoside)-7-glucoside, Rosmarinic acid, delphinidin-3,5-diglucosides, Kaempferol-3-feruloylsophoroside-7-glucoside and Phloroglucinol in PHGs. The PHGs exhibited IC50 of 51.23, 58.57, 55.41 and 53.13 μg/mL in DPPH assay, FRAP assay, TAC, Nitric oxide scavenging assays respectively. The PHGs also demonstrated IC50 of 49.97 and 36.16 μg/mL in alpha-amylase and in alpha-glucosidase inhibition assays respectively in dose dependent manner. The developed PHGs exhibited an excellent flow property. These exhibit significant in-vitro antioxidant and antidiabetic profile by virtue of flavonoid and phenolic acid derivatives.

Keywords: Antidiabetic; Antioxidant: polyherbal; Cicer arietinum; Elettaria cardamomum; HPLC-DAD; Hordeum vulgare.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Muhammad Furqan Akhtar serves as Advisory board member of Heliyon Journal.

Figures

Fig. 1
Fig. 1
The in-vitro antioxidant activity of polyherbal granules (PHGs) (a) 2,2-diphenyl 1-picrylhydrazyl (DPPH) scavenging activity, (b) Ferric reducing power activity (FRAP) inhibition activity (c) Total antioxidant capacity (TAC) (d) Nitric oxide (NO) scavenging activity assay.
Fig. 2
Fig. 2
In-vitro antidiabetic activities of poly-herbal granules (PHGs) (a) Alpha amylase inhibition activity (b) Alpha glucosidase inhibition activity of PHGs.

Similar articles

Cited by

References

    1. Wang X., Kang J., Liu Q., Tong T., Quan H. Fighting diabetes mellitus: pharmacological and non-pharmacological approaches. Curr. Pharmaceut. Des. 2020;26(39):4992–5001. - PubMed
    1. Farina F., Picascia S., Pisapia L., Barba P., Vitale S., Franzese A., et al. HLA-DQA1 and HLA-DQB1 alleles. conferring susceptibility to celiac disease and type 1 diabetes. are more expressed than non-predisposing alleles and are coordinately regulated. Cells. 2019;8(7):751. - PMC - PubMed
    1. Adnan M., Aasim M. Prevalence of type 2 diabetes mellitus in adult population of Pakistan: a meta-analysis of prospective cross-sectional surveys. Ann. Glob. Health. 2020;86(1) - PMC - PubMed
    1. Lause M., Kamboj A., Faith E.F. Dermatologic manifestations of endocrine disorders. Transl. Pediatr. 2017;6(4):300. - PMC - PubMed
    1. Kuroda N., Kusunoki Y., Osugi K., Ohigashi M., Azuma D., Ikeda H., et al. Relationships between time in range. glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: hyogo Diabetes Hypoglycemia Cognition Complications study. J. Diabetes Invest. 2021;12(2):244–253. - PMC - PubMed

LinkOut - more resources